Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CellCentric Licenses Cancer Programme To Takeda
The deal is focused into the area of epigenetics, demonstrating the commercial interest in novel epigenetic targets beyond HDACs (histone deacetylases) and DNMTs (DNA methyltransferases ). According to
The deal is focused into the area of epigenetics, demonstrating the commercial interest in novel epigenetic targets beyond HDACs (histone deacetylases) and DNMTs (DNA methyltransferases ). According to
Watson’s results include Arrow Group results since the acquisition on December 2, 2009. On an adjusted cash basis, net income for the fourth quarter 2009 increased 28% to
The FDA approved Bioguard is a non-leaching antimicrobial dressing and had its first commercial sale of the product in June 2009. The dressings serve as a barrier to
Earlier, in 2009, eight products manufactured by China Sky One Medical’s main operating subsidiary, Harbin Tian Di Ren Medical Science and Technology Company (TDR) were included on the
NanoGuardian’s NanoEncryption technology works directly on capsules, tablets, vial caps, and single-use syringes to provide a layered security strategy consisting of overt, covert and forensic security features. NanoGuardian
AST-120 adsorbs ammonia and other gut derived toxins that factor prominently in the underlying cause of mild hepatic encephalopathy (MHE). The study is a randomised, double blind, multicenter
Cantimer and Advanced Instruments have also entered into a product development agreement for Cantimer to develop a specific sensor to integrate into Advanced Instruments’ products for in-situ monitoring
The Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay is a ready-use assay that requires no mixing prior to use and has been authorized for use on the ABI 7500.
NEBNext reagents are a series of highly pure reagents that facilitate sample preparation for downstream applications, such as next generation sequencing. All reagents undergo stringent quality controls and
CORT 108297 is the lead compound from our three series of proprietary selective GR-II antagonists and is a fused-ring azadecalin. This series of compounds has demonstrated a greater